Lifeline Scientific, Inc. (LSI.L) reported that its full-year 2011 net income attributable to co. increased to $3.47 million from $2.20 million last year. On a per share basis, earnings was $0.17 versus 0.12 year-ago.
For the twelve months, net income totaled $3.27 million compared to $1.99 million previous year.
Operating profit for the period decreased to $1.9 million from $4.5 million prior year reflecting planned strategic investments in product development and geographic expansion.
The company's total revenue advanced to $25.39 million from year ago's $23.17 million, primarily due to increased unit sales of LifePort Kidney Transporter and a significant increase in sales of solutions and consumable products.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.